Global Nocturia Supply, Demand and Key Producers, 2024-2030

Description

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.

The global Nocturia market size is expected to reach $ 4080 million by 2030, rising at a market growth of 5.7% CAGR during the forecast period (2024-2030).

The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:
1. Growing Aging Population
Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.

Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.

2. Advancements in Treatment Options
Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.

Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.

Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.

3. Increasing Awareness and Diagnosis
Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.

Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.

4. Regional Growth
North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.

Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.

Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.

Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

This report studies the global Nocturia demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nocturia, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nocturia that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Nocturia total market, 2019-2030, (USD Million)
Global Nocturia total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Nocturia total market, key domestic companies, and share, (USD Million)
Global Nocturia revenue by player, revenue and market share 2019-2024, (USD Million)
Global Nocturia total market by Type, CAGR, 2019-2030, (USD Million)
Global Nocturia total market by Sale Channels, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Nocturia market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nocturia market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Sale Channels. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Nocturia Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Nocturia Market, Segmentation by Type
    Desmopressin
    Anticholinergic Drugs
    Alpha Blockers
    Diuretics
    Others

Global Nocturia Market, Segmentation by Sale Channels:
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Companies Profiled:
    Astellas Pharma
    Allergan
    Ferring Pharmaceuticals
    Eli Lilly
    GlaxoSmithKline
    Sanofi
    Pfizer
    Abbott
    Teva
    Mylan
    Novartis
    Johnson & Johnson
    Merck
    Astra Zeneca
    Bristol-Myers Squibb
    Hainan Zhonghe Pharmaceutical
    Fosun Pharma
    Hybio Pharmaceutical
    Rechon Life Science AB
    Zhejiang Conba Pharmaceutical
    Chengdu Leer Pharmaceutical
    Nanjing Xingyin Pharmaceutical Group
    Sun Pharmaceutical Industries Ltd.
    APOTEX INC
    Sagent Pharmaceuticals

Key Questions Answered
1. How big is the global Nocturia market?
2. What is the demand of the global Nocturia market?
3. What is the year over year growth of the global Nocturia market?
4. What is the total value of the global Nocturia market?
5. Who are the Major Players in the global Nocturia market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Nocturia Introduction
    1.2 World Nocturia Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Nocturia Total Market by Region (by Headquarter Location)
        1.3.1 World Nocturia Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Nocturia Revenue (2019-2030)
        1.3.3 China Based Company Nocturia Revenue (2019-2030)
        1.3.4 Europe Based Company Nocturia Revenue (2019-2030)
        1.3.5 Japan Based Company Nocturia Revenue (2019-2030)
        1.3.6 South Korea Based Company Nocturia Revenue (2019-2030)
        1.3.7 ASEAN Based Company Nocturia Revenue (2019-2030)
        1.3.8 India Based Company Nocturia Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Nocturia Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Nocturia Consumption Value (2019-2030)
    2.2 World Nocturia Consumption Value by Region
        2.2.1 World Nocturia Consumption Value by Region (2019-2024)
        2.2.2 World Nocturia Consumption Value Forecast by Region (2025-2030)
    2.3 United States Nocturia Consumption Value (2019-2030)
    2.4 China Nocturia Consumption Value (2019-2030)
    2.5 Europe Nocturia Consumption Value (2019-2030)
    2.6 Japan Nocturia Consumption Value (2019-2030)
    2.7 South Korea Nocturia Consumption Value (2019-2030)
    2.8 ASEAN Nocturia Consumption Value (2019-2030)
    2.9 India Nocturia Consumption Value (2019-2030)

3 World Nocturia Companies Competitive Analysis
    3.1 World Nocturia Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Nocturia Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Nocturia in 2023
        3.2.3 Global Concentration Ratios (CR8) for Nocturia in 2023
    3.3 Nocturia Company Evaluation Quadrant
    3.4 Nocturia Market: Overall Company Footprint Analysis
        3.4.1 Nocturia Market: Region Footprint
        3.4.2 Nocturia Market: Company Product Type Footprint
        3.4.3 Nocturia Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Nocturia Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Nocturia Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Nocturia Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Nocturia Consumption Value Comparison
        4.2.1 United States VS China: Nocturia Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Nocturia Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Nocturia Companies and Market Share, 2019-2024
        4.3.1 United States Based Nocturia Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Nocturia Revenue, (2019-2024)
    4.4 China Based Companies Nocturia Revenue and Market Share, 2019-2024
        4.4.1 China Based Nocturia Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Nocturia Revenue, (2019-2024)
    4.5 Rest of World Based Nocturia Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Nocturia Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Nocturia Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Nocturia Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Desmopressin
        5.2.2 Anticholinergic Drugs
        5.2.3 Alpha Blockers
        5.2.4 Diuretics
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Nocturia Market Size by Type (2019-2024)
        5.3.2 World Nocturia Market Size by Type (2025-2030)
        5.3.3 World Nocturia Market Size Market Share by Type (2025-2030)

6 Market Analysis by Sale Channels
    6.1 World Nocturia Market Size Overview by Sale Channels: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Sale Channels
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Sale Channels
        6.3.1 World Nocturia Market Size by Sale Channels (2019-2024)
        6.3.2 World Nocturia Market Size by Sale Channels (2025-2030)
        6.3.3 World Nocturia Market Size Market Share by Sale Channels (2019-2030)

7 Company Profiles
    7.1 Astellas Pharma
        7.1.1 Astellas Pharma Details
        7.1.2 Astellas Pharma Major Business
        7.1.3 Astellas Pharma Nocturia Product and Services
        7.1.4 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Astellas Pharma Recent Developments/Updates
        7.1.6 Astellas Pharma Competitive Strengths & Weaknesses
    7.2 Allergan
        7.2.1 Allergan Details
        7.2.2 Allergan Major Business
        7.2.3 Allergan Nocturia Product and Services
        7.2.4 Allergan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Allergan Recent Developments/Updates
        7.2.6 Allergan Competitive Strengths & Weaknesses
    7.3 Ferring Pharmaceuticals
        7.3.1 Ferring Pharmaceuticals Details
        7.3.2 Ferring Pharmaceuticals Major Business
        7.3.3 Ferring Pharmaceuticals Nocturia Product and Services
        7.3.4 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Ferring Pharmaceuticals Recent Developments/Updates
        7.3.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
    7.4 Eli Lilly
        7.4.1 Eli Lilly Details
        7.4.2 Eli Lilly Major Business
        7.4.3 Eli Lilly Nocturia Product and Services
        7.4.4 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Eli Lilly Recent Developments/Updates
        7.4.6 Eli Lilly Competitive Strengths & Weaknesses
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Details
        7.5.2 GlaxoSmithKline Major Business
        7.5.3 GlaxoSmithKline Nocturia Product and Services
        7.5.4 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 GlaxoSmithKline Recent Developments/Updates
        7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.6 Sanofi
        7.6.1 Sanofi Details
        7.6.2 Sanofi Major Business
        7.6.3 Sanofi Nocturia Product and Services
        7.6.4 Sanofi Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Sanofi Recent Developments/Updates
        7.6.6 Sanofi Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer Nocturia Product and Services
        7.7.4 Pfizer Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses
    7.8 Abbott
        7.8.1 Abbott Details
        7.8.2 Abbott Major Business
        7.8.3 Abbott Nocturia Product and Services
        7.8.4 Abbott Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Abbott Recent Developments/Updates
        7.8.6 Abbott Competitive Strengths & Weaknesses
    7.9 Teva
        7.9.1 Teva Details
        7.9.2 Teva Major Business
        7.9.3 Teva Nocturia Product and Services
        7.9.4 Teva Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Teva Recent Developments/Updates
        7.9.6 Teva Competitive Strengths & Weaknesses
    7.10 Mylan
        7.10.1 Mylan Details
        7.10.2 Mylan Major Business
        7.10.3 Mylan Nocturia Product and Services
        7.10.4 Mylan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Mylan Recent Developments/Updates
        7.10.6 Mylan Competitive Strengths & Weaknesses
    7.11 Novartis
        7.11.1 Novartis Details
        7.11.2 Novartis Major Business
        7.11.3 Novartis Nocturia Product and Services
        7.11.4 Novartis Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Novartis Recent Developments/Updates
        7.11.6 Novartis Competitive Strengths & Weaknesses
    7.12 Johnson & Johnson
        7.12.1 Johnson & Johnson Details
        7.12.2 Johnson & Johnson Major Business
        7.12.3 Johnson & Johnson Nocturia Product and Services
        7.12.4 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Johnson & Johnson Recent Developments/Updates
        7.12.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.13 Merck
        7.13.1 Merck Details
        7.13.2 Merck Major Business
        7.13.3 Merck Nocturia Product and Services
        7.13.4 Merck Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Merck Recent Developments/Updates
        7.13.6 Merck Competitive Strengths & Weaknesses
    7.14 Astra Zeneca
        7.14.1 Astra Zeneca Details
        7.14.2 Astra Zeneca Major Business
        7.14.3 Astra Zeneca Nocturia Product and Services
        7.14.4 Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Astra Zeneca Recent Developments/Updates
        7.14.6 Astra Zeneca Competitive Strengths & Weaknesses
    7.15 Bristol-Myers Squibb
        7.15.1 Bristol-Myers Squibb Details
        7.15.2 Bristol-Myers Squibb Major Business
        7.15.3 Bristol-Myers Squibb Nocturia Product and Services
        7.15.4 Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Bristol-Myers Squibb Recent Developments/Updates
        7.15.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.16 Hainan Zhonghe Pharmaceutical
        7.16.1 Hainan Zhonghe Pharmaceutical Details
        7.16.2 Hainan Zhonghe Pharmaceutical Major Business
        7.16.3 Hainan Zhonghe Pharmaceutical Nocturia Product and Services
        7.16.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
        7.16.6 Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
    7.17 Fosun Pharma
        7.17.1 Fosun Pharma Details
        7.17.2 Fosun Pharma Major Business
        7.17.3 Fosun Pharma Nocturia Product and Services
        7.17.4 Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Fosun Pharma Recent Developments/Updates
        7.17.6 Fosun Pharma Competitive Strengths & Weaknesses
    7.18 Hybio Pharmaceutical
        7.18.1 Hybio Pharmaceutical Details
        7.18.2 Hybio Pharmaceutical Major Business
        7.18.3 Hybio Pharmaceutical Nocturia Product and Services
        7.18.4 Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Hybio Pharmaceutical Recent Developments/Updates
        7.18.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
    7.19 Rechon Life Science AB
        7.19.1 Rechon Life Science AB Details
        7.19.2 Rechon Life Science AB Major Business
        7.19.3 Rechon Life Science AB Nocturia Product and Services
        7.19.4 Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 Rechon Life Science AB Recent Developments/Updates
        7.19.6 Rechon Life Science AB Competitive Strengths & Weaknesses
    7.20 Zhejiang Conba Pharmaceutical
        7.20.1 Zhejiang Conba Pharmaceutical Details
        7.20.2 Zhejiang Conba Pharmaceutical Major Business
        7.20.3 Zhejiang Conba Pharmaceutical Nocturia Product and Services
        7.20.4 Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
        7.20.6 Zhejiang Conba Pharmaceutical Competitive Strengths & Weaknesses
    7.21 Chengdu Leer Pharmaceutical
        7.21.1 Chengdu Leer Pharmaceutical Details
        7.21.2 Chengdu Leer Pharmaceutical Major Business
        7.21.3 Chengdu Leer Pharmaceutical Nocturia Product and Services
        7.21.4 Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.21.5 Chengdu Leer Pharmaceutical Recent Developments/Updates
        7.21.6 Chengdu Leer Pharmaceutical Competitive Strengths & Weaknesses
    7.22 Nanjing Xingyin Pharmaceutical Group
        7.22.1 Nanjing Xingyin Pharmaceutical Group Details
        7.22.2 Nanjing Xingyin Pharmaceutical Group Major Business
        7.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Product and Services
        7.22.4 Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.22.5 Nanjing Xingyin Pharmaceutical Group Recent Developments/Updates
        7.22.6 Nanjing Xingyin Pharmaceutical Group Competitive Strengths & Weaknesses
    7.23 Sun Pharmaceutical Industries Ltd.
        7.23.1 Sun Pharmaceutical Industries Ltd. Details
        7.23.2 Sun Pharmaceutical Industries Ltd. Major Business
        7.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Product and Services
        7.23.4 Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.23.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
        7.23.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
    7.24 APOTEX INC
        7.24.1 APOTEX INC Details
        7.24.2 APOTEX INC Major Business
        7.24.3 APOTEX INC Nocturia Product and Services
        7.24.4 APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.24.5 APOTEX INC Recent Developments/Updates
        7.24.6 APOTEX INC Competitive Strengths & Weaknesses
    7.25 Sagent Pharmaceuticals
        7.25.1 Sagent Pharmaceuticals Details
        7.25.2 Sagent Pharmaceuticals Major Business
        7.25.3 Sagent Pharmaceuticals Nocturia Product and Services
        7.25.4 Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024)
        7.25.5 Sagent Pharmaceuticals Recent Developments/Updates
        7.25.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Nocturia Industry Chain
    8.2 Nocturia Upstream Analysis
    8.3 Nocturia Midstream Analysis
    8.4 Nocturia Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Nocturia Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Nocturia Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Nocturia Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Nocturia Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Nocturia Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Nocturia Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Nocturia Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Nocturia Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Nocturia Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Nocturia Players in 2023
 Table 12. World Nocturia Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Nocturia Company Evaluation Quadrant
 Table 14. Head Office of Key Nocturia Players
 Table 15. Nocturia Market: Company Product Type Footprint
 Table 16. Nocturia Market: Company Product Application Footprint
 Table 17. Nocturia Mergers & Acquisitions Activity
 Table 18. United States VS China Nocturia Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Nocturia Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Nocturia Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Nocturia Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Nocturia Revenue Market Share (2019-2024)
 Table 23. China Based Nocturia Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Nocturia Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Nocturia Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Nocturia Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Nocturia Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Nocturia Revenue Market Share (2019-2024)
 Table 29. World Nocturia Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Nocturia Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Nocturia Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Nocturia Market Size by Sale Channels, (USD Million), 2019 & 2023 & 2030
 Table 33. World Nocturia Market Size by Sale Channels (2019-2024) & (USD Million)
 Table 34. World Nocturia Market Size by Sale Channels (2025-2030) & (USD Million)
 Table 35. Astellas Pharma Basic Information, Manufacturing Base and Competitors
 Table 36. Astellas Pharma Major Business
 Table 37. Astellas Pharma Nocturia Product and Services
 Table 38. Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Astellas Pharma Recent Developments/Updates
 Table 40. Astellas Pharma Competitive Strengths & Weaknesses
 Table 41. Allergan Basic Information, Manufacturing Base and Competitors
 Table 42. Allergan Major Business
 Table 43. Allergan Nocturia Product and Services
 Table 44. Allergan Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Allergan Recent Developments/Updates
 Table 46. Allergan Competitive Strengths & Weaknesses
 Table 47. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 48. Ferring Pharmaceuticals Major Business
 Table 49. Ferring Pharmaceuticals Nocturia Product and Services
 Table 50. Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Ferring Pharmaceuticals Recent Developments/Updates
 Table 52. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
 Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 54. Eli Lilly Major Business
 Table 55. Eli Lilly Nocturia Product and Services
 Table 56. Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Eli Lilly Recent Developments/Updates
 Table 58. Eli Lilly Competitive Strengths & Weaknesses
 Table 59. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
 Table 60. GlaxoSmithKline Major Business
 Table 61. GlaxoSmithKline Nocturia Product and Services
 Table 62. GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. GlaxoSmithKline Recent Developments/Updates
 Table 64. GlaxoSmithKline Competitive Strengths & Weaknesses
 Table 65. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 66. Sanofi Major Business
 Table 67. Sanofi Nocturia Product and Services
 Table 68. Sanofi Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Sanofi Recent Developments/Updates
 Table 70. Sanofi Competitive Strengths & Weaknesses
 Table 71. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 72. Pfizer Major Business
 Table 73. Pfizer Nocturia Product and Services
 Table 74. Pfizer Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Pfizer Recent Developments/Updates
 Table 76. Pfizer Competitive Strengths & Weaknesses
 Table 77. Abbott Basic Information, Manufacturing Base and Competitors
 Table 78. Abbott Major Business
 Table 79. Abbott Nocturia Product and Services
 Table 80. Abbott Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Abbott Recent Developments/Updates
 Table 82. Abbott Competitive Strengths & Weaknesses
 Table 83. Teva Basic Information, Manufacturing Base and Competitors
 Table 84. Teva Major Business
 Table 85. Teva Nocturia Product and Services
 Table 86. Teva Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Teva Recent Developments/Updates
 Table 88. Teva Competitive Strengths & Weaknesses
 Table 89. Mylan Basic Information, Manufacturing Base and Competitors
 Table 90. Mylan Major Business
 Table 91. Mylan Nocturia Product and Services
 Table 92. Mylan Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Mylan Recent Developments/Updates
 Table 94. Mylan Competitive Strengths & Weaknesses
 Table 95. Novartis Basic Information, Manufacturing Base and Competitors
 Table 96. Novartis Major Business
 Table 97. Novartis Nocturia Product and Services
 Table 98. Novartis Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Novartis Recent Developments/Updates
 Table 100. Novartis Competitive Strengths & Weaknesses
 Table 101. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
 Table 102. Johnson & Johnson Major Business
 Table 103. Johnson & Johnson Nocturia Product and Services
 Table 104. Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Johnson & Johnson Recent Developments/Updates
 Table 106. Johnson & Johnson Competitive Strengths & Weaknesses
 Table 107. Merck Basic Information, Manufacturing Base and Competitors
 Table 108. Merck Major Business
 Table 109. Merck Nocturia Product and Services
 Table 110. Merck Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Merck Recent Developments/Updates
 Table 112. Merck Competitive Strengths & Weaknesses
 Table 113. Astra Zeneca Basic Information, Manufacturing Base and Competitors
 Table 114. Astra Zeneca Major Business
 Table 115. Astra Zeneca Nocturia Product and Services
 Table 116. Astra Zeneca Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Astra Zeneca Recent Developments/Updates
 Table 118. Astra Zeneca Competitive Strengths & Weaknesses
 Table 119. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 120. Bristol-Myers Squibb Major Business
 Table 121. Bristol-Myers Squibb Nocturia Product and Services
 Table 122. Bristol-Myers Squibb Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Bristol-Myers Squibb Recent Developments/Updates
 Table 124. Bristol-Myers Squibb Competitive Strengths & Weaknesses
 Table 125. Hainan Zhonghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 126. Hainan Zhonghe Pharmaceutical Major Business
 Table 127. Hainan Zhonghe Pharmaceutical Nocturia Product and Services
 Table 128. Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Hainan Zhonghe Pharmaceutical Recent Developments/Updates
 Table 130. Hainan Zhonghe Pharmaceutical Competitive Strengths & Weaknesses
 Table 131. Fosun Pharma Basic Information, Manufacturing Base and Competitors
 Table 132. Fosun Pharma Major Business
 Table 133. Fosun Pharma Nocturia Product and Services
 Table 134. Fosun Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 135. Fosun Pharma Recent Developments/Updates
 Table 136. Fosun Pharma Competitive Strengths & Weaknesses
 Table 137. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 138. Hybio Pharmaceutical Major Business
 Table 139. Hybio Pharmaceutical Nocturia Product and Services
 Table 140. Hybio Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 141. Hybio Pharmaceutical Recent Developments/Updates
 Table 142. Hybio Pharmaceutical Competitive Strengths & Weaknesses
 Table 143. Rechon Life Science AB Basic Information, Manufacturing Base and Competitors
 Table 144. Rechon Life Science AB Major Business
 Table 145. Rechon Life Science AB Nocturia Product and Services
 Table 146. Rechon Life Science AB Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 147. Rechon Life Science AB Recent Developments/Updates
 Table 148. Rechon Life Science AB Competitive Strengths & Weaknesses
 Table 149. Zhejiang Conba Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 150. Zhejiang Conba Pharmaceutical Major Business
 Table 151. Zhejiang Conba Pharmaceutical Nocturia Product and Services
 Table 152. Zhejiang Conba Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 153. Zhejiang Conba Pharmaceutical Recent Developments/Updates
 Table 154. Zhejiang Conba Pharmaceutical Competitive Strengths & Weaknesses
 Table 155. Chengdu Leer Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 156. Chengdu Leer Pharmaceutical Major Business
 Table 157. Chengdu Leer Pharmaceutical Nocturia Product and Services
 Table 158. Chengdu Leer Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 159. Chengdu Leer Pharmaceutical Recent Developments/Updates
 Table 160. Chengdu Leer Pharmaceutical Competitive Strengths & Weaknesses
 Table 161. Nanjing Xingyin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 162. Nanjing Xingyin Pharmaceutical Group Major Business
 Table 163. Nanjing Xingyin Pharmaceutical Group Nocturia Product and Services
 Table 164. Nanjing Xingyin Pharmaceutical Group Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 165. Nanjing Xingyin Pharmaceutical Group Recent Developments/Updates
 Table 166. Nanjing Xingyin Pharmaceutical Group Competitive Strengths & Weaknesses
 Table 167. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
 Table 168. Sun Pharmaceutical Industries Ltd. Major Business
 Table 169. Sun Pharmaceutical Industries Ltd. Nocturia Product and Services
 Table 170. Sun Pharmaceutical Industries Ltd. Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 171. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 172. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
 Table 173. APOTEX INC Basic Information, Manufacturing Base and Competitors
 Table 174. APOTEX INC Major Business
 Table 175. APOTEX INC Nocturia Product and Services
 Table 176. APOTEX INC Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 177. APOTEX INC Recent Developments/Updates
 Table 178. APOTEX INC Competitive Strengths & Weaknesses
 Table 179. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 180. Sagent Pharmaceuticals Major Business
 Table 181. Sagent Pharmaceuticals Nocturia Product and Services
 Table 182. Sagent Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 183. Sagent Pharmaceuticals Recent Developments/Updates
 Table 184. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
 Table 185. Global Key Players of Nocturia Upstream (Raw Materials)
 Table 186. Global Nocturia Typical Customers


List of Figures
 Figure 1. Nocturia Picture
 Figure 2. World Nocturia Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Nocturia Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Nocturia Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Nocturia Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Nocturia Revenue (2019-2030) & (USD Million)
 Figure 13. Nocturia Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Nocturia Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Nocturia Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Nocturia by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Nocturia Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Nocturia Markets in 2023
 Figure 27. United States VS China: Nocturia Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Nocturia Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Nocturia Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Nocturia Market Size Market Share by Type in 2023
 Figure 31. Desmopressin
 Figure 32. Anticholinergic Drugs
 Figure 33. Alpha Blockers
 Figure 34. Diuretics
 Figure 35. Others
 Figure 36. World Nocturia Market Size Market Share by Type (2019-2030)
 Figure 37. World Nocturia Market Size by Sale Channels, (USD Million), 2019 & 2023 & 2030
 Figure 38. World Nocturia Market Size Market Share by Sale Channels in 2023
 Figure 39. Hospital Pharmacies
 Figure 40. Retail Pharmacies
 Figure 41. Online Pharmacies
 Figure 42. World Nocturia Market Size Market Share by Sale Channels (2019-2030)
 Figure 43. Nocturia Industrial Chain
 Figure 44. Methodology
 Figure 45. Research Process and Data Source

Companies Mentioned

Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Novartis
Johnson & Johnson
Merck
Astra Zeneca
Bristol-Myers Squibb
Hainan Zhonghe Pharmaceutical
Fosun Pharma
Hybio Pharmaceutical
Rechon Life Science AB
Zhejiang Conba Pharmaceutical
Chengdu Leer Pharmaceutical
Nanjing Xingyin Pharmaceutical Group
Sun Pharmaceutical Industries Ltd.
APOTEX INC
Sagent Pharmaceuticals